Who
Christine E. Seidman
Director
Company insider
Files Form 4 as: Director, Merck & Company.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Mar 2020
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12555.915 at $145.31 | filing |
| 30 Jun 2026filed 1 Jul 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12563.23 at $128.50 | filing |
| 30 Jun 2026filed 1 Jul 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12563.23 at $128.50 | filing |
| 29 May 2026filed 2 Jun 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K1,853.1 at $118.72 | filing |
| 29 May 2026filed 2 Jun 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K1,853.1 at $118.72 | filing |
| 31 Mar 2026filed 1 Apr 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12567.545 at $120.29 | filing |
| 31 Mar 2026filed 1 Apr 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12667.55 at $120.29 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12577.19 at $105.26 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12577.19 at $105.26 | filing |
| 30 Sep 2025filed 2 Oct 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12596.81 at $83.93 | filing |
| 30 Jun 2025filed 2 Jul 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,125102.64 at $79.16 | filing |
| 30 May 2025filed 3 Jun 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K2,863.09 at $76.84 | filing |
| 31 Mar 2025filed 2 Apr 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12590.52 at $89.76 | filing |
| 31 Dec 2024filed 3 Jan 2025 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12581.67 at $99.48 | filing |
| 30 Sep 2024filed 1 Oct 2024 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12571.55 at $113.56 | filing |
| 28 Jun 2024filed 2 Jul 2024 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12565.63 at $123.80 | filing |
| 31 May 2024filed 4 Jun 2024 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $220K1,752.43 at $125.54 | filing |
| 28 Mar 2024filed 29 Mar 2024 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12561.58 at $131.95 | filing |
| 29 Dec 2023filed 2 Jan 2024 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12574.53 at $109.02 | filing |
| 29 Sep 2023filed 3 Oct 2023 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,12578.92 at $102.95 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.